These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37367101)

  • 61. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
    Lee JH; Kim YG; Lee J
    Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.
    Rossoni RD; Dos Santos Velloso M; Figueiredo LMA; Martins CP; Jorge AOC; Junqueira JC
    Folia Microbiol (Praha); 2018 May; 63(3):307-314. PubMed ID: 29170992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A functional link between hyphal maintenance and quorum sensing in Candida albicans.
    Polke M; Sprenger M; Scherlach K; Albán-Proaño MC; Martin R; Hertweck C; Hube B; Jacobsen ID
    Mol Microbiol; 2017 Feb; 103(4):595-617. PubMed ID: 27623739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis.
    Yano J; Yu A; Fidel PL; Noverr MC
    PLoS One; 2016; 11(7):e0159692. PubMed ID: 27453977
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
    Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New antifungal 4-chloro-3-nitrophenyldifluoroiodomethyl sulfone reduces the Candida albicans pathogenicity in the Galleria mellonella model organism.
    Staniszewska M; Gizińska M; Kazek M; de Jesús González-Hernández R; Ochal Z; Mora-Montes HM
    Braz J Microbiol; 2020 Mar; 51(1):5-14. PubMed ID: 31486049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. WMR Peptide as Antifungal and Antibiofilm against Albicans and Non-Albicans Candida Species: Shreds of Evidence on the Mechanism of Action.
    Maione A; Bellavita R; de Alteriis E; Galdiero S; Albarano L; La Pietra A; Guida M; Parrilli E; D'Angelo C; Galdiero E; Falanga A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216270
    [No Abstract]   [Full Text] [Related]  

  • 69. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
    Yu LH; Wei X; Ma M; Chen XJ; Xu SB
    Antimicrob Agents Chemother; 2012 Feb; 56(2):770-5. PubMed ID: 22106223
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-
    Araújo D; Mil-Homens D; Henriques M; Silva S
    Mol Ther Nucleic Acids; 2022 Mar; 27():517-523. PubMed ID: 35036062
    [No Abstract]   [Full Text] [Related]  

  • 71. Biofilm of Candida albicans: formation, regulation and resistance.
    Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
    J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sodium New Houttuyfonate Inhibits
    Wu J; Wu D; Zhao Y; Si Y; Mei L; Shao J; Wang T; Yan G; Wang C
    Front Microbiol; 2020; 11():2075. PubMed ID: 32983053
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development.
    Liang X; Chen D; Wang J; Liao B; Shen J; Ye X; Wang Z; Zhu C; Gou L; Zhou X; Cheng L; Ren B; Zhou X
    Int J Oral Sci; 2023 Sep; 15(1):40. PubMed ID: 37699886
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
    Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.
    Zhang L; Chang W; Sun B; Groh M; Speicher A; Lou H
    PLoS One; 2011; 6(12):e28953. PubMed ID: 22174935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the antifungal photodynamic activity of Thymophylla pentachaeta extracts against Candida albicans and its virulence factors.
    Cordisco E; Petenatti E; Svetaz L; Sortino M
    Phytomedicine; 2021 Sep; 90():153608. PubMed ID: 34148723
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN; Campos-Silva R; Ramos LS; Trentin DS; Macedo AJ; Branquinha MH; Santos ALS
    FEMS Yeast Res; 2018 Nov; 18(7):. PubMed ID: 30052907
    [TBL] [Abstract][Full Text] [Related]  

  • 78. β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.
    Gowri M; Sofi Beaula W; Biswal J; Dhamodharan P; Saiharish R; Rohan prasad S; Pitani R; Kandaswamy D; Raghunathan R; Jeyakanthan J; Rayala SK; Venkatraman G
    Biochim Biophys Acta; 2016 Apr; 1860(4):636-47. PubMed ID: 26723175
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Flo8 transcription factor is essential for hyphal development and virulence in Candida albicans.
    Cao F; Lane S; Raniga PP; Lu Y; Zhou Z; Ramon K; Chen J; Liu H
    Mol Biol Cell; 2006 Jan; 17(1):295-307. PubMed ID: 16267276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Xia J; Qian F; Xu W; Zhang Z; Wei X
    Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.